DK1519936T3 - Fremgangsmåde til fremstilling af nevirapin - Google Patents
Fremgangsmåde til fremstilling af nevirapinInfo
- Publication number
- DK1519936T3 DK1519936T3 DK03736801T DK03736801T DK1519936T3 DK 1519936 T3 DK1519936 T3 DK 1519936T3 DK 03736801 T DK03736801 T DK 03736801T DK 03736801 T DK03736801 T DK 03736801T DK 1519936 T3 DK1519936 T3 DK 1519936T3
- Authority
- DK
- Denmark
- Prior art keywords
- nevirapine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39269002P | 2002-06-28 | 2002-06-28 | |
| PCT/US2003/017376 WO2004002988A1 (fr) | 2002-06-28 | 2003-06-02 | Procede de preparation de la nevirapine ameliore |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1519936T3 true DK1519936T3 (da) | 2008-03-03 |
Family
ID=30000920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03736801T DK1519936T3 (da) | 2002-06-28 | 2003-06-02 | Fremgangsmåde til fremstilling af nevirapin |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6680383B1 (fr) |
| EP (1) | EP1519936B1 (fr) |
| JP (1) | JP4209388B2 (fr) |
| KR (1) | KR100981261B1 (fr) |
| CN (1) | CN1280293C (fr) |
| AR (1) | AR039771A1 (fr) |
| AT (1) | ATE382621T1 (fr) |
| AU (1) | AU2003237336B2 (fr) |
| BR (1) | BR0312071A (fr) |
| CA (2) | CA2480046C (fr) |
| DE (1) | DE60318444T2 (fr) |
| DK (1) | DK1519936T3 (fr) |
| EA (1) | EA007497B1 (fr) |
| EC (1) | ECSP045514A (fr) |
| ES (1) | ES2299709T3 (fr) |
| HK (1) | HK1080848A1 (fr) |
| HR (1) | HRP20041214A2 (fr) |
| IL (1) | IL163977A0 (fr) |
| ME (1) | MEP53908A (fr) |
| MX (1) | MXPA04010405A (fr) |
| MY (1) | MY131847A (fr) |
| NO (1) | NO329109B1 (fr) |
| NZ (1) | NZ537803A (fr) |
| PE (1) | PE20040586A1 (fr) |
| PL (1) | PL371496A1 (fr) |
| RS (1) | RS50900B (fr) |
| TW (1) | TWI270548B (fr) |
| UA (1) | UA80140C2 (fr) |
| WO (1) | WO2004002988A1 (fr) |
| ZA (1) | ZA200407107B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007010352A1 (fr) * | 2005-07-19 | 2007-01-25 | Emcure Pharmaceuticals Limited | Procédé amélioré de fabrication industrielle de la névirapine |
| JP2007031391A (ja) * | 2005-07-29 | 2007-02-08 | Koei Chem Co Ltd | アルキルアミノピリジンカルボニトリルの製造方法 |
| BR112012014762A2 (pt) * | 2009-12-17 | 2016-03-29 | Univ Northwest | forma polimorfa de nevirapina e sua preparação |
| CN102167699A (zh) * | 2011-03-17 | 2011-08-31 | 湖南博奥德生物医药技术开发有限公司 | 一种奈韦拉平制备方法 |
| WO2012168949A2 (fr) * | 2011-06-06 | 2012-12-13 | Laurus Labs Private Limited | Procédé de préparation de névirapine |
| CN102321015A (zh) * | 2011-06-30 | 2012-01-18 | 江苏德峰药业有限公司 | 一种抗艾滋病药物奈韦拉平关键中间体 2-(环丙胺基）-3-甲酸吡啶的制备方法 |
| WO2016118586A1 (fr) * | 2015-01-20 | 2016-07-28 | Virginia Commonwealth University | Synthèse économique, à rendement élevé de névirapine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
2003
- 2003-02-06 UA UAA200500685A patent/UA80140C2/uk unknown
- 2003-06-02 RS YUP-1102/04A patent/RS50900B/sr unknown
- 2003-06-02 ES ES03736801T patent/ES2299709T3/es not_active Expired - Lifetime
- 2003-06-02 NZ NZ537803A patent/NZ537803A/en not_active IP Right Cessation
- 2003-06-02 CA CA2480046A patent/CA2480046C/fr not_active Expired - Fee Related
- 2003-06-02 DE DE60318444T patent/DE60318444T2/de not_active Expired - Lifetime
- 2003-06-02 PL PL03371496A patent/PL371496A1/xx not_active IP Right Cessation
- 2003-06-02 KR KR1020047021296A patent/KR100981261B1/ko not_active IP Right Cessation
- 2003-06-02 MX MXPA04010405A patent/MXPA04010405A/es active IP Right Grant
- 2003-06-02 CN CNB038105896A patent/CN1280293C/zh not_active Expired - Fee Related
- 2003-06-02 BR BR0312071-6A patent/BR0312071A/pt not_active IP Right Cessation
- 2003-06-02 DK DK03736801T patent/DK1519936T3/da active
- 2003-06-02 EP EP03736801A patent/EP1519936B1/fr not_active Expired - Lifetime
- 2003-06-02 IL IL16397703A patent/IL163977A0/xx not_active IP Right Cessation
- 2003-06-02 ME MEP-539/08A patent/MEP53908A/xx unknown
- 2003-06-02 WO PCT/US2003/017376 patent/WO2004002988A1/fr active IP Right Grant
- 2003-06-02 JP JP2004517609A patent/JP4209388B2/ja not_active Expired - Fee Related
- 2003-06-02 AT AT03736801T patent/ATE382621T1/de active
- 2003-06-02 AU AU2003237336A patent/AU2003237336B2/en not_active Ceased
- 2003-06-02 EA EA200401535A patent/EA007497B1/ru not_active IP Right Cessation
- 2003-06-02 CA CA2708442A patent/CA2708442C/fr not_active Expired - Fee Related
- 2003-06-05 US US10/454,991 patent/US6680383B1/en not_active Expired - Lifetime
- 2003-06-26 PE PE2003000642A patent/PE20040586A1/es not_active Application Discontinuation
- 2003-06-27 TW TW092117662A patent/TWI270548B/zh not_active IP Right Cessation
- 2003-06-27 AR ARP030102323A patent/AR039771A1/es unknown
- 2003-06-27 MY MYPI20032417A patent/MY131847A/en unknown
-
2004
- 2004-09-06 ZA ZA200407107A patent/ZA200407107B/en unknown
- 2004-10-12 NO NO20044332A patent/NO329109B1/no not_active IP Right Cessation
- 2004-12-27 EC EC2004005514A patent/ECSP045514A/es unknown
- 2004-12-27 HR HR20041214A patent/HRP20041214A2/xx not_active Application Discontinuation
-
2006
- 2006-01-18 HK HK06100817A patent/HK1080848A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
| DK1277722T3 (da) | Fremgangsmåde til fremstilling af methanol | |
| DK1611108T3 (da) | Fremgangsmåde til fremstilling af telmisartan | |
| DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
| DK1451143T3 (da) | Fremgangsmåder til fremstilling af O-desmethylvenlafaxin | |
| DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| DK1840125T3 (da) | Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater | |
| DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1407037T3 (da) | Fremgangsmåde til fremstilling af tagatose | |
| DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1572613T3 (da) | Fremgangsmåde til fremstilling af benzophenoner | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
| DK1519928T3 (da) | Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner | |
| DK1519936T3 (da) | Fremgangsmåde til fremstilling af nevirapin | |
| DK1727792T3 (da) | Fremgangsmåde til fremstilling af semicarbazoner | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| DK1503995T3 (da) | Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer | |
| DK1692137T3 (da) | Fremgangsmåde til fremstilling af tubulinininhibitorer | |
| DK1578720T3 (da) | Fremgangsmåde til fremstilling af gamma-cyhalothrin |